GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis
I continued to investigate ways to improve myself and learned about peptide therapy
Q: Does the AFN L-Carnitine Liquid Supplement contain allergens
How do genetic variants like GLP1R rs6923761 affect my weight loss
Serious risks are less common but include pancreatitis and, based on animal studies, a theoretical risk of thyroid C-cell tumors, which is why GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma
Abbreviations AEs: Adverse events NAEs: Neurological adverse events FDA: The Food and Drug Administration FAERS: The FDA Adverse Event Reporting System GLP-1 RAs: Glucagon-like peptide-1 receptor agonists ADRs: Adverse drug reactions PTs: Preferred Terms SOCs: System Organ Classes IQR: Interquartile range ROR: Reporting odds ratio CI: Confidence interval PRR: Proportional reporting ratio BCPNN: Bayesian Confidence Propagation Neural Network EBGM: Empirical Bayesian geometric mean EBGM05: The lower limit of 95% CI of EBGM IC: Information component IC025: The lower limit of 95% CI of the IC VANs: Vagal afferent neurons T2DM: Type 2 diabetes mellitus OR: Odds ratios References Targher, G., Mantovani, A
